Our objective
Since 1997, the firm has focused on the clinical development of mushroom nutrition to prove their inherent health benefits that allow for the development of disease modifying therapies.
MRL products contain both the mycelium and primordia (young fruitbody) of the mushroom cultivated into a biomass on an edible, sterile (autoclaved substrate). The cultivation process ensures that the biomass is free from contamination by other fungi or bacteria and that heavy metals and pesticides are two distinct issues.
Following cultivation to ISO 22000:2018 standards, the biomass is dried, powdered and tableted to FSSC 22000 standards. The powder presentations are accredited to EU and UK organic standards.
Please see this video for more information on Mycology Research Laboratories Ltd.
view our productsOur Quality Standards
Mycology Research Laboratories has a commitment to the product quality and all the production process is garantee and certified by several institutes.
learn moreScientific Advisory Board
In 1998, MRL formed an international Scientific Advisory Board (SAB) to advise MRL on all mushroom nutriton clinical development and basic research, both in the human and animal health areas. The SAB members are:
-
Dr. Stefan Arver (MD, Ph.D)
Reproductive Medical Center
Karolinska Hospital
Stockholm, Sweden
-
Dr. Gosse Bruinsma (MD)
Founder
Ciurem Pharma Inc.
Ottawa, Canada
-
Mr. Tom Chapman (Pharmacist)
Essential Nutrition Ltd.
Brough, United Kingdom
-
Mr. Malcolm Clark (MA)
Co-Founder Gourmet Mushrooms
Sebastopol, California, USA
-
Prof. Vittorio Calabrese (MD, Ph.D)
University of Catania
Catania, Italy
-
Prof. Tito Fernandes (Vet., Ph D)
University of Lúrio
Nampula, Mozambique
-
Dr. Abraham Kryger (DMD, MD)
Preventative Medicine Clinic of Monterey
California, United States
-
Dr. Jean Monro (MD)
Breakspear Hospital
Hempel Hempstead, United Kingdom
-
Mr. Karel Simonovsky (Lic. TCM)
Founder Pragon
Prague, Czech Republic
-
Mr. Charles Wauters (Pharmacist)
Founder Natuurapotheek
Den Haag, Holland